Incyte (INCY) EPS (Basic) (2010 - 2026)

Incyte (INCY) has 17 years of EPS (Basic) data on file, last reported at $2.92 in Q2 2026.

• Quarterly EPS (Basic) rose 39.99% year-over-year to $2.92 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.05 (up 79.25% YoY) and the FY2025 annual result came in at $6.59, up 4085.58% from the prior year.
• EPS (Basic) advanced to $2.92 in Q2 2026, from $1.52 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $2.92 in Q2 2026 to a low of -$2.04 in Q2 2024.
• A 5-year average of $0.86 and a median of $0.79 in 2023 frame the typical range for EPS (Basic).
• The widest YoY moves for EPS (Basic): up 675.92% in 2024, down 323.5% in 2024.
• Tracing INCY's EPS (Basic) over 5 years: stood at $0.13 in 2022, then jumped by 601.38% to $0.9 in 2023, then advanced by 8.05% to $0.97 in 2024, then soared by 57.81% to $1.53 in 2025, then jumped by 90.62% to $2.92 in 2026.
• The last three EPS (Basic) figures came in at $2.92 (Q2 2026), $1.52 (Q1 2026), and $1.53 (Q4 2025), per Business Quant data.